Back to results
US 2003/0216413 A1Published application
Catecholamine pharmaceutical compositions and methods
OwnerRobert S. Root-Bernstein, Patrick F. Dilloninventors
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerRobert S. Root-Bernstein, Patrick F. Dilloninventors
Estimating the term…
Pharmaceutical compositions and method using adrenergic compounds and complement compounds. Compositions are provided comprising: (c) a subefficacious amount of an adrenergic compound; and (d) a safe and effective amount of a complement to the adrenergic compound. Methods are also provided comprising the administration of: (c) a low dose of an adrenergic compound; and (d) a safe and effective amount of a complement to said adrenergic compound. Preferably, the adrenergic compound is a catecholamine. Complements include ascorbates, opioids, polycarboxylic acid chelaters, and mixtures thereof. Preferred complements include ascorbates, particularly ascorbic acid. Methods include the treatment of neurological disorders, hypotension, forward failure, backward failure, congestive heart failure, shock, hypertension, hemorrhage, disorders associated with anesthesia, chronic obstructive pulmonary disease, asthma, colic, Crohn's disease, anaphylaxis, interstitial cystitis, overactive bladder syndrome, premature labor, myethsenia gravis, and glaucoma.
A pharmaceutical composition comprising:
A pharmaceutical composition comprising:
A method of treating a disorder associated with an adrenergic receptor in a human or other animal subject, comprising:
A method of treating a disorder associated with an adrenergic receptor in a human or other animal subject, comprising:
A method of determining a regimen for regulating an adrenergic receptor in human or other animal subjects, comprising:
Dependencies are inferred from the claim text.